Abstract:The aim of this study was to investigate if mortality during a 13-year follow-up varied between normotensive subjects, screen-detected hypertensive subjects, and subjects with antihypertensive medication at baseline. A population-based screening and intervention program identified 2659 apparently healthy, middle-aged cardiovascular-risk persons in southwestern Finland. Screen-detected hypertension was verified by home blood pressure measurements. Lifestyle counseling was provided for all participants and preventive medications were started or intensified if needed. All-cause and cardiovascular mortality were obtained from the official statistics. Screen-detected hypertension was diagnosed in 17% of the participants, 51% were normotensive and 32% had antihypertensive medication at baseline. The screen-detected hypertensives had higher mean blood pressure and cholesterol levels than the two other groups. Altogether 289 subjects died during the follow-up, 83 (29%) from cardiovascular disease. Those with screen-detected hypertension had decreased cardiovascular mortality risk compared to the medicated hypertensives [sHR 0.40 (95% CI: 0.19 to 0.88, p = 0.023)], and comparable with that of the normotensives [sHR 0.53 (95% CI: 0.24 to 1.15)]. Newly diagnosed diabetes at baseline was a powerful predictor of cardiovascular mortality [sHR 2.71 (95% CI: 1.57 to 4.69)]. Early detection of hypertension and timely multifactorial intervention seem to be important in preventing hypertension-related mortality.

What problem does this paper attempt to address?

This paper aims to explore the mortality differences among normotensive individuals not taking antihypertensive drugs, hypertension - detected by screening, and those already taking antihypertensive drugs at baseline during a 13 - year follow - up period. Specifically, the research objective is to evaluate the impact of screening - detected hypertension on all - cause mortality and cardiovascular disease (CVD) mortality. ### Research Background Hypertension is the most important but treatable risk factor for cardiovascular disease (CVD) and death worldwide, causing approximately 10.5 million deaths each year. Hypertension is estimated to account for about 50% of all heart - disease - and - stroke - related deaths, and these diseases are the leading causes of morbidity and mortality globally. Although the diagnosis of hypertension is relatively simple and effective and low - cost drugs are widely available, hypertension remains generally undetected or undertreated. The World Heart Federation and the World Health Organization have emphasized the importance of increasing hypertension awareness and early detection and have advocated high - risk and population - based strategies to manage and control hypertension. ### Research Methods This study was a prospective cohort study that included residents aged 45 to 70 years in two semi - rural towns, Harjavalta and Kokemäki, in south - western Finland. Through a cardiovascular risk factor survey, laboratory tests, and lifestyle counseling, 2,659 healthy middle - aged individuals with a relatively high cardiovascular risk were screened out. The study was divided into three groups: - **Normotensive group**: No use of antihypertensive drugs at baseline, and the average blood pressure measured by nurses was less than 140/90 mmHg or the home blood pressure was less than 135/85 mmHg. - **Screening - detected hypertension group**: No use of antihypertensive drugs at baseline, and the average of home blood pressure measurements was systolic blood pressure ≥ 135 mmHg or diastolic blood pressure ≥ 85 mmHg. - **Antihypertensive - drug - taking group**: Already using antihypertensive drugs at baseline. ### Main Results - **Overall mortality**: During the 13 - year follow - up period, a total of 289 people died, of which 83 died of cardiovascular diseases. - **Adjusted all - cause mortality**: After adjusting for age, sex, total cholesterol, newly diagnosed type 2 diabetes, years of education, current smoking status, level of leisure - time physical activity, and body mass index, the differences in all - cause mortality among the groups were not statistically significant (p = 0.053). - **Adjusted cardiovascular mortality**: There were significant differences in adjusted CVD mortality among the groups (p = 0.012). Compared with the antihypertensive - drug - taking group, the CVD death risk in the screening - detected hypertension group was significantly lower (sHR 0.40, 95% CI: 0.19 to 0.88, p = 0.023), which was comparable to that in the normotensive group (sHR 0.53, 95% CI: 0.24 to 1.15, p = 0.11). - **Other independent predictors**: Older age, male sex, newly diagnosed type 2 diabetes, and smoking were also independent predictors of CVD death. ### Conclusion This study shows that in the primary care setting, screening for hypertension and timely multi - factor intervention can significantly reduce the long - term CVD death risk, making it comparable to the CVD risk in normotensive individuals. This highlights the importance of early detection of hypertension and multi - factor intervention in CVD - at - risk populations.

Multifactorial prevention program for cardiovascular disease in primary care: hypertension status and effect on mortality